Overview of Ocular Anti-Vascular Endothelial Growth Factor Therapy in the Management of Diabetic Eye Complications.
作者信息
Akiyode Oluwaranti, Tran Christine
机构信息
Howard University College of Pharmacy, Washington, D.C.
出版信息
Diabetes Spectr. 2016 Feb;29(1):44-9. doi: 10.2337/diaspect.29.1.44.
Abstract
摘要
相似文献
1
Overview of Ocular Anti-Vascular Endothelial Growth Factor Therapy in the Management of Diabetic Eye Complications.糖尿病眼部并发症治疗中眼部抗血管内皮生长因子疗法概述
Diabetes Spectr. 2016 Feb;29(1):44-9. doi: 10.2337/diaspect.29.1.44.
2
Ocular anti-VEGF therapy for diabetic retinopathy: overview of clinical efficacy and evolving applications.抗血管内皮生长因子药物治疗糖尿病视网膜病变：临床疗效概述及应用进展。
Diabetes Care. 2014 Apr;37(4):900-5. doi: 10.2337/dc13-1990.
3
[Angiogenesis and inhibition of angiogenesis in the eye].[眼部的血管生成与血管生成抑制]
Klin Monbl Augenheilkd. 1997 Jun;210(6):341-51. doi: 10.1055/s-2008-1035072.
4
The renin-angiotensin system influences ocular endothelial cell proliferation in diabetes: transgenic and interventional studies.肾素-血管紧张素系统对糖尿病状态下眼内内皮细胞增殖的影响：转基因及干预性研究
Am J Pathol. 2003 Jan;162(1):151-60. doi: 10.1016/S0002-9440(10)63806-0.
5
[Alternative splicing of vascular endothelial growth factor A and ocular neovascularization].[血管内皮生长因子A的可变剪接与眼部新生血管形成]
Zhonghua Yan Ke Za Zhi. 2011 Apr;47(4):373-7.
6
Vascular endothelial growth factor and its receptors in control and diabetic rat eyes.对照和糖尿病大鼠眼中的血管内皮生长因子及其受体
Lab Invest. 1998 Aug;78(8):1017-27.
7
Aflibercept: A Review of Its Use in the Management of Diabetic Eye Complications.阿柏西普：用于治疗糖尿病眼部并发症的综述
J Pharm Pract. 2017 Oct;30(5):534-540. doi: 10.1177/0897190016647232. Epub 2016 May 10.
8
Elevated TGFbeta signaling inhibits ocular vascular development.升高的转化生长因子β信号传导会抑制眼部血管发育。
Dev Biol. 2001 Sep 1;237(1):45-53. doi: 10.1006/dbio.2001.0360.
9
Intravitreal anti-vascular endothelial growth factor for choroidal neovascularization in ocular histoplasmosis.玻璃体内注射抗血管内皮生长因子治疗眼组织胞浆菌病脉络膜新生血管化
Retin Cases Brief Rep. 2014 Winter;8(1):24-9. doi: 10.1097/ICB.0b013e3182a48bcc.
10
Diabetic retinopathy is associated with a switch in splicing from anti- to pro-angiogenic isoforms of vascular endothelial growth factor.糖尿病视网膜病变与血管内皮生长因子从抗血管生成异构体向促血管生成异构体的剪接转变有关。
Diabetologia. 2005 Nov;48(11):2422-7. doi: 10.1007/s00125-005-1951-8. Epub 2005 Sep 29.
引用本文的文献
1
Exacerbation of pigment epithelial detachment following aflibercept: A case of bevacizumab rescue.阿柏西普治疗后色素上皮脱离加重：贝伐单抗挽救治疗1例
Am J Ophthalmol Case Rep. 2021 Oct 5;24:101216. doi: 10.1016/j.ajoc.2021.101216. eCollection 2021 Dec.
2
Applications of Artificial Intelligence for the Detection, Management, and Treatment of Diabetic Retinopathy.人工智能在糖尿病视网膜病变的检测、管理和治疗中的应用。
Int Ophthalmol Clin. 2020 Fall;60(4):127-145. doi: 10.1097/IIO.0000000000000333.
3
Investigation of expression and effects of TGF-β1 and MMP-9 in lens epithelial cells of diabetic cataract rats.糖尿病性白内障大鼠晶状体上皮细胞中TGF-β1和MMP-9的表达及作用研究
Exp Ther Med. 2019 Jun;17(6):4522-4526. doi: 10.3892/etm.2019.7471. Epub 2019 Apr 8.
本文引用的文献
1
Intravitreal Aflibercept for Diabetic Macular Edema: 100-Week Results From the VISTA and VIVID Studies.玻璃体内注射阿柏西普治疗糖尿病性黄斑水肿：VISTA 和 VIVID 研究的 100 周结果。
Ophthalmology. 2015 Oct;122(10):2044-52. doi: 10.1016/j.ophtha.2015.06.017. Epub 2015 Jul 18.
2
Systematic review and mixed treatment comparison of intravitreal aflibercept with other therapies for diabetic macular edema (DME).玻璃体内注射阿柏西普与其他疗法治疗糖尿病性黄斑水肿（DME）的系统评价和混合治疗比较
BMC Ophthalmol. 2015 May 15;15:52. doi: 10.1186/s12886-015-0035-x.
3
Comparing aflibercept, bevacizumab, and ranibizumab for DME: analysis of DRCR Protocol T.阿柏西普、贝伐单抗和雷珠单抗治疗糖尿病性黄斑水肿的比较：糖尿病性视网膜病变临床研究网络（DRCR）协议T分析
Ophthalmic Surg Lasers Imaging Retina. 2015 Mar;46(3):302-5. doi: 10.3928/23258160-20150304-01.
4
Population pharmacokinetics of pegaptanib sodium (Macugen(®)) in patients with diabetic macular edema.聚乙二醇化 aptanib 钠（Macugen(®)）在糖尿病性黄斑水肿患者中的群体药代动力学。
Clin Ophthalmol. 2015 Feb 16;9:323-35. doi: 10.2147/OPTH.S74050. eCollection 2015.
5
Intravitreal bevacizumab injection alone or combined with triamcinolone versus macular photocoagulation in bilateral diabetic macular edema; application of bivariate generalized linear mixed model with asymmetric random effects in a subgroup of a clinical trial.玻璃体内注射贝伐单抗单独或联合曲安奈德与黄斑光凝治疗双侧糖尿病性黄斑水肿的比较；在一项临床试验的亚组中应用具有非对称随机效应的双变量广义线性混合模型
J Ophthalmic Vis Res. 2014 Oct-Dec;9(4):453-60. doi: 10.4103/2008-322X.150818.
6
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.阿柏西普、贝伐单抗或雷珠单抗治疗糖尿病性黄斑水肿。
N Engl J Med. 2015 Mar 26;372(13):1193-203. doi: 10.1056/NEJMoa1414264. Epub 2015 Feb 18.
7
Ocular complications of diabetes mellitus.糖尿病的眼部并发症。
World J Diabetes. 2015 Feb 15;6(1):92-108. doi: 10.4239/wjd.v6.i1.92.
8
(9) Microvascular complications and foot care.（9）微血管并发症与足部护理。
Diabetes Care. 2015 Jan;38 Suppl:S58-66. doi: 10.2337/dc15-S012.
9
Diabetic Retinopathy-Update on Prevention Techniques, Present Therapies, and New Leads.糖尿病视网膜病变——预防技术、现有治疗方法及新进展综述
US Ophthalmic Rev. 2014;7(1):54-58. doi: 10.17925/usor.2014.07.01.54.
10
Anti-VEGF for the management of diabetic macular edema.抗血管内皮生长因子药物治疗糖尿病黄斑水肿。
J Immunol Res. 2014;2014:632307. doi: 10.1155/2014/632307. Epub 2014 Feb 5.
Zotero 插件